Skip to main content
SpringerLink
Log in

Present role and future perspectives of the evaluation of the effect of primary chemotherapy by breast imaging

  • Review Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Recently, primary chemotherapy has been used not only for locally advanced breast cancers but also operable cases in an adjuvant setting. Therefore, many randomized clinical trials for primary chemotherapy have been coducted all over the world, with the result that more than one-third of the cases have become nonpalpable (clinical CR). On the contrary, accurate determination of the surgical margin has become more difficult. If some cancer remains as a nonpalpable lesion, it must be detected. Breast MRI has been assuming an important role in the assessment of the extent of cancer and does so more accurately than conventional modalities such as mammography and ultrasonography. Image-guided biopsy or mapping is promising and should be developed as soon as possible. In this article, some promising modalities for the detection of residual lesions after primary chemotherapy are extensively reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, Nash AG, Ford HT: A reduction in requirements for mastectomy in a randomised trial of neoad-juvant chemoendcrine therapy in primary breast cancer.Ann Oncol 9:1179–1184,1998.

    Article  PubMed  CAS  Google Scholar 

  2. McMasters KM, Hunt KK: Neoadjuvant chemotherapy, locally advanced breast cancer, and quality of life.J Clin Oncol 17:441–444,1999.

    PubMed  CAS  Google Scholar 

  3. Valero V, Buzdar AU, McNeese M, Singletary E, Hortobagyi GN: Primary chemotherapy in the treatment of breast cancer: the University of Texas M.D. Anderson Cancer Center experience.Clin Breast Cancer 3 Suppl 2:S63–68, 2002.

    Article  PubMed  Google Scholar 

  4. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL, Wolmark N: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18.J Clin Oncol 15:2483–2493,1997.

    PubMed  CAS  Google Scholar 

  5. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB Jr, Hoehn JL, Lees AW, Dimitrov HV, Bear HD: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.J Clin Oncol 16:2672–2685, 1998.

    PubMed  CAS  Google Scholar 

  6. Nakamura S, Kenjo H, Nishino T, Kazama T, Doi O, Suzuki K 3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET.Breast Cancer 8:351–354,2001.

    Article  PubMed  CAS  Google Scholar 

  7. Nakamura S, Kenjo H, Nishino T, Kazama T, Doi O, Suzuki K: Efficacy of 3D-mammography for breast conserving surgery after neoadjuvant chemotherapy.Breast Cancer 9:15–19, 2002.

    Article  PubMed  Google Scholar 

  8. Mamounas EP: Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: updated results from NSABP B-27.Proc Am Soc Clin Oncol (ASCO), May 18-21, 2002, Orlando, FL (Abstr 140).

  9. Anscher M, Jones P, Prosnitz LR, Blackstock W, Hebert M, Reddick R, Tucker A, Dodge R, Leight G Jr, Iglehart JD: Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.Ann Surg 218:22–28,1993.

    Article  PubMed  CAS  Google Scholar 

  10. Fortin A, Larochelle M, Laverdiere J, Lavertu S, Tremblay D: Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy.J Clin Oncol 17:101–109,1999.

    PubMed  CAS  Google Scholar 

  11. Nakamura S, Sugiura T, Nishio T, Abe O, Sakurai K: Three dimensional MRI for indication of breast conserving surgery. XXX World Congress of the International College of Surgeons (abstr), 1507–1511,1996.

  12. Harms SE, Flamig DP, Evans WP, Harries SA, Brown S: MR imaging of the breast: current status and future potential.Am J Roentgenol 163:1039–1047,1994.

    CAS  Google Scholar 

  13. Pierce WB, Harms SE, Flamig DP, Griffery RH, Evans WP, Hagans JE: Three-dimensional gadoli-num-enhanced MR imaging of the breast.Radiology 181:757–763,1991.

    PubMed  CAS  Google Scholar 

  14. Stelling CB: MR imaging of the breast for cancer evaluation. Current status and future directions.Radiol Clin North Am 33:1187–1204,1995.

    PubMed  CAS  Google Scholar 

  15. Jeffrey CW, Gillian N: MR imaging of the breast.Radiology 196:593–610,1995.

    Google Scholar 

  16. Schinitt SJ, Connolly JL, Harris Jr, Hellman S, Cohen RB: Pathologic prediction of early local reccurrence in stage I and II breast cancer treated by primary radiation therapy.Cancer 53:1049–1057,1984.

    Article  Google Scholar 

  17. Esserman L, Hylton N, Yssa L, Barclay J, Frankel S, Sickles E: Utility of magnetic resonance imaging in the managiment of breast cancer: evidence for improved preoperative staging.J Clin Oncol 17:110–119, 1999.

    PubMed  CAS  Google Scholar 

  18. Akashi-Tanaka S: Clinical use of contrast enhanced computed tomography for decision making in breast conserving surgery.Breast Cancer 4:280–284,1997.

    Article  Google Scholar 

  19. Akashi-Tanaka S, Fukutomi T, Miyakawa K, Uchiyama N, Tsuda H: Diagnostic value of contrast-enhanced computed tomography for diagnosing the intra-ductal component of breast cancer.Breast Cancer Res Treat 49:79–86,1998.

    Article  PubMed  CAS  Google Scholar 

  20. Bassa P, Kim EE, Inoue T, Wong FC, Korkmaz M, Yang DJ, Wong WH, Hicks KW, Buzdar AU, Podoloff DA: Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breastcancer.J Nucl Med 37:931–938,1996.

    PubMed  CAS  Google Scholar 

  21. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R: Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.J Clin Oncol 11:2101–2111, 1993.

    PubMed  CAS  Google Scholar 

  22. Jansson T, Westlin JE, Ahlstrom H, Lilja A, Lang-storm B, Bergh J: Positron emission tomography studies in patients with locally advanced and/or meta-static breast cancer: a method forearly therapy evaluation?J Clin Oncol 13:1470–1477,1995.

    PubMed  CAS  Google Scholar 

  23. Moon DH, Maddahi J, Silverman DH, Glaspy JA, Phelps ME, Hoh CK: Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.J Nucl Med 39:431–435, 1998.

    PubMed  CAS  Google Scholar 

  24. Oshida M, Uno K, Suzuki M, Nagashima T, Hashimoto H, Yagata H, Shishikura T, Imazeki K, Nakajima N: Predicting the prognoses of breast carcinoma patients with positoron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose.Cancer 82:2227–2234,1998.

    Article  PubMed  CAS  Google Scholar 

  25. Minn H, Soini I: [18F] fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer.Eur J Nucl Med 15:61–66,1998.

    Article  Google Scholar 

  26. Pusztai L, Ayers M, Stec J, Hortobagyi GN: Clinical application of cDNA Microarrys in Oncology.Oncologist 8:252–258,2003.

    Article  PubMed  CAS  Google Scholar 

  27. Chang J: Gene expression patterns for docetaxel sensitivity and resistance in patients with locally advanced breast cancer.Cancer Conference Highlights 7:8–10,2003.

    Google Scholar 

  28. Nakamura S, Hayashi N, Enokido K, Tsunoda H, Suzuki K: Predictive factors of neoadjuvant chemotherapy analyzed by 3D MR-mammography, Sept 25–27, 2003, Jena, Germany,Eur Radiol 13:D52,2003.

    Google Scholar 

  29. Noguchi M: Radiofrequency ablation treatment for breast cancer to meet the next challenge: how to treat primary tumor without surgery.Breast Cancer 10:1–3, 2003.

    Article  PubMed  Google Scholar 

  30. Harms SE: MRI guided laser ablation of breast cancer, Sept 25–27, 2003, Jena, Germany,Eur Radiol 13:D16–20,2003.

    Google Scholar 

  31. Nelson MT, Garwood M, Meisamy S, Boland P, Ever-son L, Emery T: High field [T4] MRI imaging and spectroscopy of breast cancer, Proc 3rd International Congress on MR-mammography, Sept 25–27, 2003, Jena, Germany,Eur Radiol 13:D82,2003.

    Google Scholar 

  32. Jagannathan NR: Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.Br J Cancer 84:1016–1022, 2001.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, St.Luke’s International Hospital, 9-1 Akashi-cho, Chuo-ku, 104-0044, Tokyo, Japan

    Seigo Nakamura

Authors
  1. Seigo Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seigo Nakamura.

About this article

Cite this article

Nakamura, S. Present role and future perspectives of the evaluation of the effect of primary chemotherapy by breast imaging. Breast Cancer 11, 134–138 (2004). https://doi.org/10.1007/BF02968292

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02968292

Key words

Search

Navigation